| pubmed-article:19250113 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19250113 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:19250113 | lifeskim:mentions | umls-concept:C1282910 | lld:lifeskim |
| pubmed-article:19250113 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:19250113 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:19250113 | lifeskim:mentions | umls-concept:C1167956 | lld:lifeskim |
| pubmed-article:19250113 | pubmed:dateCreated | 2009-3-2 | lld:pubmed |
| pubmed-article:19250113 | pubmed:abstractText | Left ventricular (LV) postero-lateral scar and total scar burden are factors responsible for a poor response to cardiac resynchronization therapy (CRT). Contrast-enhanced magnetic resonance imaging (CMR) and (99m)Tc-2-methoxy isobutyl isonitrile single photon emission computed tomography (SPECT) perfusion imaging are widely used to detect myocardial scar tissue; however, their ability to detect regional scars and predict a positive response to CRT has not been fully evaluated. | lld:pubmed |
| pubmed-article:19250113 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19250113 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19250113 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19250113 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19250113 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19250113 | pubmed:issn | 1540-8159 | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:TadaHiroshiH | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:OshimaShigeru... | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:ToyamaTakujiT | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:NaitoShigetoS | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:TaniguchiKoic... | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:KoyamaKeikoK | lld:pubmed |
| pubmed-article:19250113 | pubmed:author | pubmed-author:YokokawaMikiM | lld:pubmed |
| pubmed-article:19250113 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19250113 | pubmed:volume | 32 Suppl 1 | lld:pubmed |
| pubmed-article:19250113 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19250113 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19250113 | pubmed:pagination | S57-62 | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:meshHeading | pubmed-meshheading:19250113... | lld:pubmed |
| pubmed-article:19250113 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19250113 | pubmed:articleTitle | Magnetic resonance imaging is superior to cardiac scintigraphy to identify nonresponders to cardiac resynchronization therapy. | lld:pubmed |
| pubmed-article:19250113 | pubmed:affiliation | Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan. | lld:pubmed |
| pubmed-article:19250113 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19250113 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19250113 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:19250113 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
